Skip to main content
SpringerLink
Log in

Stereotactic Cranial Radiosurgery for Metastatic Non-small-cell Lung Carcinoma

  • Chapter
  • First Online:
Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies

  • 1076 Accesses

Abstract

Brain metastasis (BM) is either present at the initial presentation or emerges somewhere during the treatment course in up to 64 % patients. Therapeutic strategies of BM include chemotherapy, neurosurgery, whole brain radiotherapy (WBRT), stereotactic radiosurgery (SRS), or different combinations of them. In general, the priority of the single- or combination-treatment modality is usually decided in view of the information about the patient’s performance status, extracranial disease status, number, size, total volume, and localization of the BM. Based on the comparative phase III trials, with its high-precision capability in delivery of large doses of RT in a single session, SRS appears to be a noninvasive alternative to neurosurgery for single BM. Similarly, available data suggests almost equal effectiveness of SRS in ≤3 versus >3 BM situations. Therefore, in lack of any documented evidence suggesting inefficacy of SRS in patients with >3 BM, it is reasonable to offer SRS for suitable patients with larger BM. Tumor bed SRS (TB-SRS) is a relatively new treatment approach with no randomized data published to date. Available literature on use of TB-SRS is encouraging, but much is still unknown about the required doses and optimal margins, which underlines the need for appropriately designed future studies on this highly specific issue. Clinically, SRS alone results in better neurocognitive functions compared to WBRT and is equivalent to neurosurgery with no overall survival differences compared to these treatment options. Therefore, SRS alone can be safely utilized in particular patients with close follow-ups for distant brain recurrences. Technically, SRS can be performed in various ways by using Gamma Knife or high-capacity novel linear accelerators. Absolutely some technical differences exist among diverse SRS hardware and related treatment planning systems with associated pros and cons, but available comparative outcomes do not suggest any differences in clinical outcomes including the tumor control and survival rates, as long as the fundamental tenets of SRS are pursued.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.

    Article  PubMed  Google Scholar 

  2. Liu H, Ma HF, Chen YK. Association between GSTM1 polymorphisms and lung cancer: an updated meta-analysis. Genet Mol Res. 2015;14(1):1385–92.

    Article  CAS  PubMed  Google Scholar 

  3. Sorensen JB, Hansen HH, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol. 1988;6(9):1474–80.

    CAS  PubMed  Google Scholar 

  4. Kocher M, Wittig A, Piroth MD, et al. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2014;190(6):521–32.

    Article  PubMed  Google Scholar 

  5. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):45–68.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist. 2007;12(7):884–98.

    Article  CAS  PubMed  Google Scholar 

  7. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45(7):741–4.

    Article  CAS  PubMed  Google Scholar 

  8. Chin LS, Regine FW. Principles and practice of stereotactic radiosurgery. New York: Springer; 2008.

    Book  Google Scholar 

  9. Berk L. An overview of radiotherapy trials for the treatment of brain metastases. Oncology (Williston Park). 1995;9(11):1205–12; discussion 12–6, 19.

    CAS  Google Scholar 

  10. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

    Article  CAS  PubMed  Google Scholar 

  11. Langley RR, Fidler IJ. The biology of brain metastasis. Clin Chem. 2013;59(1):180–9.

    Article  CAS  PubMed  Google Scholar 

  12. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest. 1983;49(2):140–7.

    CAS  PubMed  Google Scholar 

  13. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75(1):5–14.

    Article  PubMed  Google Scholar 

  14. Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg. 2001;122(3):548–53.

    Article  CAS  PubMed  Google Scholar 

  15. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29(2):134–41.

    Article  PubMed  PubMed Central  Google Scholar 

  16. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39(6):789–96.

    Article  CAS  PubMed  Google Scholar 

  17. Berghmans T, Paesmans M, Sculier JP. Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol. 2011;3(3):127–38.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980;45(8):2220–4.

    Article  CAS  PubMed  Google Scholar 

  19. Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012;30(4):419–25.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Abrahams JM, Torchia M, Putt M, Kaiser LR, Judy KD. Risk factors affecting survival after brain metastases from non-small cell lung carcinoma: a follow-up study of 70 patients. J Neurosurg. 2001;95(4):595–600.

    Article  CAS  PubMed  Google Scholar 

  21. Weltman E, Salvajoli JV, Brandt RA, et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys. 2000;46(5):1155–61.

    Article  CAS  PubMed  Google Scholar 

  22. Venur VA, Ahluwalia MS. Prognostic scores for brain metastasis patients: use in clinical practice and trial design. Chin Clin Oncol. 2015;4(2):18.

    PubMed  Google Scholar 

  23. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys. 1991;20(1):53–8.

    Article  CAS  PubMed  Google Scholar 

  24. Phillips TL, Scott CB, Leibel SA, Rotman M, Weigensberg IJ. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys. 1995;33(2):339–48.

    Article  CAS  PubMed  Google Scholar 

  25. Sause WT, Crowley JJ, Morantz R, et al. Solitary brain metastasis: results of an RTOG/SWOG protocol evaluation surgery + RT versus RT alone. Am J Clin Oncol. 1990;13(5):427–32.

    Article  CAS  PubMed  Google Scholar 

  26. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745–51.

    Article  CAS  PubMed  Google Scholar 

  27. Park JY, Moon KS, Lee KH, et al. Gamma knife radiosurgery for elderly patients with brain metastases: evaluation of scoring systems that predict survival. BMC Cancer. 2015;15:54.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nieder C, Andratschke N, Grosu AL, Molls M. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Strahlenther Onkol. 2003;179(1):16–20.

    Article  PubMed  Google Scholar 

  29. Rades D, Dziggel L, Haatanen T, et al. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys. 2011;80(4):1122–7.

    Article  PubMed  Google Scholar 

  30. Lorenzoni J, Devriendt D, Massager N, et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys. 2004;60(1):218–24.

    Article  PubMed  Google Scholar 

  31. Nieder C, Geinitz H, Molls M. Validation of the graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res. 2008;28(5B):3015–7.

    PubMed  Google Scholar 

  32. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363(9422):1665–72.

    Article  PubMed  Google Scholar 

  33. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510–4.

    Article  PubMed  Google Scholar 

  34. Antoni D, Noel G. Radiotherapy of brain metastases according to the GPA score (Graded Prognostic Assessment). Cancer Radiother. 2013;17(5–6):424–7.

    Article  CAS  PubMed  Google Scholar 

  35. Tabouret E, Metellus P, Goncalves A, et al. Assessment of prognostic scores in brain metastases from breast cancer. Neuro-Oncology. 2014;16(3):421–8.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Luo J, Zhu H, Tang Y, et al. Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy. Int J Clin Exp Med. 2014;7(12):5217–25.

    PubMed  PubMed Central  Google Scholar 

  37. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998;16(7):2522–7.

    CAS  PubMed  Google Scholar 

  38. Shaw EG, Rosdhal R, D’Agostino Jr RB, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006;24(9):1415–20.

    Article  CAS  PubMed  Google Scholar 

  39. Ganz JC. Stereotactic and radiosurgery research in Sweden. Prog Brain Res. 2014;215:57–66.

    Article  PubMed  Google Scholar 

  40. Thompson BG, Coffey RJ, Flickinger JC, Lunsford LD. Stereotactic radiosurgery of small intracranial tumors: neuropathological correlation in three patients. Surg Neurol. 1990;33(2):96–104.

    Article  CAS  PubMed  Google Scholar 

  41. Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys. 2014;88(2):254–62.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494–500.

    Article  CAS  PubMed  Google Scholar 

  43. Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys. 1994;29(4):711–7.

    Article  CAS  PubMed  Google Scholar 

  44. Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol. 2008;87(3):299–307.

    Article  PubMed  Google Scholar 

  45. Qin H, Wang C, Jiang Y, Zhang X, Zhang Y, Ruan Z. Patients with single brain metastasis from non-small cell lung cancer equally benefit from stereotactic radiosurgery and surgery: a systematic review. Med Sci Monit. 2015;21:144–52.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Vuong DA, Rades D, van Eck AT, Horstmann GA, Busse R. Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer’s perspective: stereotactic radiosurgery versus surgical resection. Clin Neurol Neurosurg. 2013;115(3):276–84.

    Article  PubMed  Google Scholar 

  47. Caruso JP, Moosa S, Fezeu F, Ramesh A, Sheehan JP. A cost comparative study of Gamma Knife radiosurgery versus open surgery for intracranial pathology. J Clin Neurosci. 2015;22(1):184–8.

    Article  PubMed  Google Scholar 

  48. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037–44.

    Article  PubMed  Google Scholar 

  49. Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22(1):157–65.

    Article  CAS  PubMed  Google Scholar 

  50. Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys. 2002;52(2):333–8.

    Article  PubMed  Google Scholar 

  51. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483–91.

    Article  CAS  PubMed  Google Scholar 

  52. Patchell RA, Regine WF, Loeffler JS, Sawaya R, Andrews DW, Chin LS. Radiosurgery plus whole-brain radiation therapy for brain metastases. JAMA. 2006;296(17):2089–90; author reply 90–1.

    Article  CAS  PubMed  Google Scholar 

  53. Wang TJ, Saad S, Qureshi YH, et al. Outcomes of gamma knife radiosurgery, bi-modality & tri-modality treatment regimens for patients with one or multiple brain metastases: the Columbia University Medical Center experience. J Neurooncol. 2015;122(2):399–408.

    Article  CAS  PubMed  Google Scholar 

  54. Pinkham MB, Whitfield GA, Brada M. New developments in intracranial stereotactic radiotherapy for metastases. Clin Oncol (R Coll Radiol). 2015;27(5):316–23.

    Article  CAS  Google Scholar 

  55. Skeie BS, Skeie GO, Enger PO, et al. Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival. World Neurosurg. 2011;75(5–6):684–91; discussion 598–603.

    Article  PubMed  Google Scholar 

  56. Chen JC, Petrovich Z, O’Day S, et al. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery. 2000;47(2):268–79; discussion 79–81.

    Article  CAS  PubMed  Google Scholar 

  57. Serizawa T, Yamamoto M, Sato Y, et al. Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J Neurosurg. 2010;113(Suppl):48–52.

    PubMed  Google Scholar 

  58. Chang WS, Kim HY, Chang JW, Park YG, Chang JH. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg. 2010;113(Suppl):73–8.

    PubMed  Google Scholar 

  59. Likhacheva A, Pinnix CC, Parikh NR, et al. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2013;85(3):656–61.

    Article  PubMed  Google Scholar 

  60. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94(10):2698–705.

    Article  PubMed  Google Scholar 

  61. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol. 1993;33(6):583–90.

    Article  CAS  PubMed  Google Scholar 

  62. Ebinu JO, Lwu S, Monsalves E, et al. Gamma knife radiosurgery for the treatment of cystic cerebral metastases. Int J Radiat Oncol Biol Phys. 2013;85(3):667–71.

    Article  PubMed  Google Scholar 

  63. Flickinger JC. Radiotherapy and radiosurgical management of brain metastases. Curr Oncol Rep. 2001;3(6):484–9.

    Article  CAS  PubMed  Google Scholar 

  64. Kim M, Cheok S, Chung LK, et al. Characteristics and treatments of large cystic brain metastasis: radiosurgery and stereotactic aspiration. Brain Tumor Res Treat. 2015;3(1):1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291–8.

    Article  CAS  PubMed  Google Scholar 

  66. Murai T, Ogino H, Manabe Y, et al. Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study. Clin Oncol (R Coll Radiol). 2014;26(3):151–8.

    Article  CAS  Google Scholar 

  67. O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys. 2003;55(5):1169–76.

    Article  PubMed  Google Scholar 

  68. Amsbaugh MJ, Boling W, Woo S. Tumor bed radiosurgery: an emerging treatment for brain metastases. J Neurooncol. 2015;123(2):197–203.

    Article  CAS  PubMed  Google Scholar 

  69. Gans JH, Raper DM, Shah AH, et al. The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery. 2013;72(3):317–25; discussion 25–6.

    Article  PubMed  Google Scholar 

  70. Roberge D, Parney I, Brown PD. Radiosurgery to the postoperative surgical cavity: who needs evidence? Int J Radiat Oncol Biol Phys. 2012;83(2):486–93.

    Article  PubMed  Google Scholar 

  71. Kelly PJ, Lin YB, Yu AY, et al. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Biol Phys. 2012;82(1):95–101.

    Article  PubMed  Google Scholar 

  72. Kim PK, Ellis TL, Stieber VW, et al. Gamma Knife surgery targeting the resection cavity of brain metastasis that has progressed after whole-brain radiotherapy. J Neurosurg. 2006;105(Suppl):75–8.

    PubMed  Google Scholar 

  73. Brennan C, Yang TJ, Hilden P, et al. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys. 2014;88(1):130–6.

    Article  PubMed  Google Scholar 

  74. Asher AL, Burri SH, Wiggins WF, et al. A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. Int J Radiat Oncol Biol Phys. 2014;88(4):899–906.

    Article  PubMed  Google Scholar 

  75. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):1485–9.

    Article  CAS  PubMed  Google Scholar 

  76. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  77. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer. 1981;48(2):384–94.

    Article  CAS  PubMed  Google Scholar 

  78. Hazuka MB, Kinzie JJ. Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys. 1988;15(2):433–7.

    Article  CAS  PubMed  Google Scholar 

  79. Wong WW, Schild SE, Sawyer TE, Shaw EG. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys. 1996;34(3):585–90.

    Article  CAS  PubMed  Google Scholar 

  80. Kurtz G, Zadeh G, Gingras-Hill G, et al. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection. Int J Radiat Oncol Biol Phys. 2014;88(1):137–42.

    Article  PubMed  Google Scholar 

  81. Noel G, Proudhom MA, Valery CA, et al. Radiosurgery for re-irradiation of brain metastasis: results in 54 patients. Radiother Oncol. 2001;60(1):61–7.

    Article  CAS  PubMed  Google Scholar 

  82. Alexander 3rd E, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995;87(1):34–40.

    Article  PubMed  Google Scholar 

  83. Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol. 1988;6(3):543–51.

    CAS  PubMed  Google Scholar 

  84. Valery CA, Cornu P, Noel G, et al. Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg. 2003;81(1–4):115–9.

    PubMed  Google Scholar 

  85. Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev. 2012;4:CD003869.

    PubMed  Google Scholar 

  86. Soffietti R, Kocher M, Abacioglu UM, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31(1):65–72.

    Article  PubMed  Google Scholar 

  87. Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol. 2009;27(1):78–84.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Welzel G, Fleckenstein K, Schaefer J, et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys. 2008;72(5):1311–8.

    Article  PubMed  Google Scholar 

  89. Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007;68(5):1388–95.

    Article  PubMed  Google Scholar 

  90. Langley RE, Stephens RJ, Nankivell M, et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol). 2013;25(3):e23–30.

    Article  CAS  Google Scholar 

  91. Doyle DM, Einhorn LH. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases. Int J Radiat Oncol Biol Phys. 2008;70(5):1361–4.

    Article  PubMed  Google Scholar 

  92. DiBiase SJ, Chin LS, Ma L. Influence of gamma knife radiosurgery on the quality of life in patients with brain metastases. Am J Clin Oncol. 2002;25(2):131–4.

    Article  PubMed  Google Scholar 

  93. Peschel RE. Notice: recently published book: proton therapy and radiosurgery, H. Breuer, B.J. Smit, springer-verlag; 2000. Int J Cancer. 2000;90(2):112.

    Article  PubMed  Google Scholar 

  94. Wu A, Lindner G, Maitz AH, et al. Physics of gamma knife approach on convergent beams in stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 1990;18(4):941–9.

    Article  CAS  PubMed  Google Scholar 

  95. Gill SS, Thomas DG, Warrington AP, Brada M. Relocatable frame for stereotactic external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1991;20(3):599–603.

    Article  CAS  PubMed  Google Scholar 

  96. Fuss M, Salter BJ, Rassiah P, Cheek D, Cavanaugh SX, Herman TS. Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy. Technol Cancer Res Treat. 2004;3(1):59–67.

    Article  PubMed  Google Scholar 

  97. Guckenberger M, Roesch J, Baier K, Sweeney RA, Flentje M. Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery. Radiat Oncol. 2012;7:63.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Ramakrishna N, Rosca F, Friesen S, Tezcanli E, Zygmanszki P, Hacker F. A clinical comparison of patient setup and intra-fraction motion using frame-based radiosurgery versus a frameless image-guided radiosurgery system for intracranial lesions. Radiother Oncol. 2010;95(1):109–15.

    Article  PubMed  Google Scholar 

  99. Choi CY, Chang SD, Gibbs IC, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys. 2012;84(2):336–42.

    Article  PubMed  Google Scholar 

  100. Wang CC, Floyd SR, Chang CH, et al. Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy x 3 daily fractions regimen. J Neurooncol. 2012;106(3):601–10.

    Article  PubMed  Google Scholar 

  101. Scoccianti S, Detti B, Gadda D, et al. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist’s guide for delineation in everyday practice. Radiother Oncol. 2015;114(2):230–8.

    Article  PubMed  Google Scholar 

  102. Sadun AA GS, Bose S. Chapter 34: anatomy of the visual sensory system. In: William T, Edward AJ, editors. Duane’s ophthalmology, foundations, vol. 1. Philadelphia, USA, Lippincott Williams & Wilkins. 2005.

    Google Scholar 

  103. Pacholke HD, Amdur RJ, Schmalfuss IM, Louis D, Mendenhall WM. Contouring the middle and inner ear on radiotherapy planning scans. Am J Clin Oncol. 2005;28(2):143–7.

    Article  PubMed  Google Scholar 

  104. Shehata MK, Young B, Reid B, et al. Stereotactic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys. 2004;59(1):87–93.

    Article  PubMed  Google Scholar 

  105. Minniti G, Esposito V, Clarke E, et al. Multidose stereotactic radiosurgery (9 Gy x 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys. 2013;86(4):623–9.

    Article  PubMed  Google Scholar 

  106. Shaw E, Kline R, Gillin M, et al. Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys. 1993;27(5):1231–9.

    Article  CAS  PubMed  Google Scholar 

  107. Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 2006;105(Suppl):194–201.

    PubMed  Google Scholar 

  108. Feuvret L, Noel G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006;64(2):333–42.

    Article  PubMed  Google Scholar 

  109. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg. 2000;93 Suppl 3:219–22.

    PubMed  Google Scholar 

  110. Lomax NJ, Scheib SG. Quantifying the degree of conformity in radiosurgery treatment planning. Int J Radiat Oncol Biol Phys. 2003;55(5):1409–19.

    Article  PubMed  Google Scholar 

  111. Timmerman RD. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol. 2008;18(4):215–22.

    Article  PubMed  Google Scholar 

  112. Leber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998;88(1):43–50.

    Article  CAS  PubMed  Google Scholar 

  113. Grimm J, LaCouture T, Croce R, Yeo I, Zhu Y, Xue J. Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. J Appl Clin Med Phys. 2011;12(2):3368.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey

    Erkan Topkan MD & Yurday Ozdemir

  2. Department of Radiation Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey

    Ugur Selek MD

  3. Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    Ugur Selek MD

Authors
  1. Erkan Topkan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yurday Ozdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ugur Selek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erkan Topkan MD .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Hacettepe University, Faculty of Med., Ankara, Turkey

    Gokhan Ozyigit

  2. Department of Radiation Oncology, Koc University, Faculty of Medicine, Istanbul, Turkey

    Ugur Selek

  3. Department of Radiation Oncology, Baskent University School of Medicine, Adana, Turkey

    Erkan Topkan

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Topkan, E., Ozdemir, Y., Selek, U. (2016). Stereotactic Cranial Radiosurgery for Metastatic Non-small-cell Lung Carcinoma. In: Ozyigit, G., Selek, U., Topkan, E. (eds) Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-319-28761-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28761-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28759-1

  • Online ISBN: 978-3-319-28761-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation